Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-ß/Smad3 signaling pathways Eduardo E. Vargas-Pozada; Erika Ramos-Tovar; Consuelo Acero-Hernández; Irina Cardoso-Lezama; Silvia Galindo-Gómez; Víctor Tsutsumi; Pablo Muriel;

Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease Ashi Mittal; Nishu Choudhary; Sudrishti Chaudhary; Anupama Kumari; Archana Rastogi; Guresh Kumar; Jaswinder Singh Maras; Shiv K Sarin; Shvetank Sharma;

Liver fibrosis: More than meets the eye Amedeo Lonardo;